scholarly article | Q13442814 |
P50 | author | Wan-Ting Huang | Q37842426 |
Wan-Chin Chen | Q83265195 | ||
Hao-Yuan Cheng | Q96067491 | ||
P2093 | author name string | Angela Song-En Huang | |
Yu-Ju Chou | |||
P2860 | cites work | Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 |
Influenza-associated hospitalizations in the United States | Q29619463 | ||
Estimating influenza deaths in Canada, 1992-2009. | Q30356489 | ||
On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic | Q30387593 | ||
Effectiveness of antiviral prophylaxis coupled with contact tracing in reducing the transmission of the influenza A (H1N1-2009): a systematic review | Q30425995 | ||
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials | Q34460803 | ||
Guidance for practitioners on the use of antiviral drugs to control influenza outbreaks in long-term care facilities in Canada, 2014-2015 season | Q35158142 | ||
Newly emerging mutations in the matrix genes of the human influenza A(H1N1)pdm09 and A(H3N2) viruses reduce the detection sensitivity of real-time reverse transcription-PCR | Q37546597 | ||
Oseltamivir for control of influenza at mass gatherings | Q38107017 | ||
Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic review | Q38174300 | ||
Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15. | Q38403538 | ||
Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial | Q40152886 | ||
Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial | Q40264783 | ||
High morbidity and mortality associated with an outbreak of influenza A(H3N2) in a psycho-geriatric facility | Q40284346 | ||
Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match | Q42244861 | ||
Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011. | Q42280448 | ||
Outbreaks of influenza-like illness in long-term care facilities in Winnipeg, Canada | Q42286840 | ||
ECDC expert opinion on efficacy and effectiveness of neuraminidase inhibitors published for public consultation | Q42924849 | ||
Detection and control of influenza outbreaks in well-vaccinated nursing home populations | Q45051230 | ||
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). | Q45152293 | ||
Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility. | Q45169775 | ||
Summer outbreak of respiratory disease in an Australian prison due to an influenza A/Fujian/411/2002(H3N2)-like virus | Q45508575 | ||
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America | Q48585293 | ||
The Tamiflu trials | Q87840532 | ||
P433 | issue | 2 | |
P304 | page(s) | 287-292 | |
P577 | publication date | 2018-01-28 | |
P1433 | published in | Influenza and Other Respiratory Viruses | Q15765099 |
P1476 | title | Containing influenza outbreaks with antiviral use in long-term care facilities in Taiwan, 2008-2014. | |
P478 | volume | 12 |
Q64134362 | Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa |
Q92127195 | Potential lethal outbreak of coronavirus disease (COVID-19) among the elderly in retirement homes and long-term facilities, France, March 2020 |
Q92023764 | Recommendations for protecting against and mitigating the COVID-19 pandemic in long-term care facilities |